[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"laparoscopy\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:laparoscopy":29},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,9,0,[8,50,76,106,134,164,190,215,244],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":30,"overallStatus":37,"whyStopped":4,"lastUpdateSubmitDate":38,"lastUpdatePostDateStruct":39,"startDateStruct":42,"completionDateStruct":44,"leadSponsor":46,"locationsCount":49},"100613000","paired-comparison-of-svv-and-pvi-accuracy-100613000",false,"NCT07260890","Paired Comparison of SVV and PVI Accuracy","Diagnostic Accuracy of Stroke Volume Variation (SVV) vs Pleth Variability Index (PVI) for Predicting Fluid Responsiveness in Laparoscopic Major Abdominal Surgery-A Prospective, Paired, Cohort Study","Inclusion Criteria:\n\n* Age ≥18 years\n* ASA physical status I-III\n* Elective laparoscopic major abdominal surgery under general anesthesia\n* Arterial line in place for clinical care\n* Able to provide informed consent\n* Arterial and plethysmographic waveforms adequate for measurement\n\nExclusion Criteria:\n\n* linically significant arrhythmia (e.g., atrial fibrillation with irregular R-R)\n* Severe valvular heart disease or intracardiac shunt\n* Pregnancy\n* Severe right-heart failure or condition where a fluid bolus is unsafe\n* Ongoing hemodynamic instability requiring rapid vasoactive titration at assessment\n* Persistently unreliable arterial\u002Fpleth signals despite optimization\n* Any situation the anesthesiologist judges that the fluid challenge is unsafe",true,"ALL","19 Years",{"count":20,"type":21},300,"ESTIMATED","OBSERVATIONAL","This study will compare two operating-room monitors-stroke volume variation (SVV, from the arterial line) and the Pleth Variability Index (PVI, from the pulse oximeter)-to see which one more accurately predicts whether giving a small fluid bolus will improve the heart's pumping during laparoscopic major abdominal surgery. Adults having elective surgery under general anesthesia will receive two small, timed 250-mL crystalloid infusions as part of routine care (one before and one after creation of the pneumoperitoneum). The research team will record SVV and PVI values just before and three minutes after each infusion while keeping these readings hidden from the clinicians so that usual care is not changed. No experimental drugs or devices are used. The main goal is to learn which index better identifies \"fluid responsiveness,\" so future care can be safer and more consistent. Potential risks are minimal and relate to the small fluid boluses (temporary changes in blood pressure or heart rate); the test stops if the anesthesiologist has any safety concerns. There is no direct benefit to participants, but results may help guide fluid therapy for similar patients in the future. The study is being conducted at a single academic hospital in the Republic of Korea and plans to enroll about 300 adults.",[25,26,27,28,29],"Perioperative Care","Fluid Therapy","Monitoring, Physiologic","Hemodynamics","Laparoscopy",[31,32,33,34,35,36],"stroke volume variation; SVV","Pleth Variability Index; PVI","fluid responsiveness","goal-directed fluid therapy; GDFT","pneumoperitoneum","diagnostic accuracy; ROC; AUROC","RECRUITING","2026-06-24",{"date":40,"type":41},"2026-06-26","ACTUAL",{"date":43,"type":21},"2026-07-01",{"date":45,"type":21},"2026-08-30",{"name":47,"class":48},"Wonkwang University Hospital","OTHER",1,{"id":51,"slug":52,"hasResults":11,"nctId":53,"briefTitle":54,"officialTitle":55,"acronym":56,"eligibilityCriteria":57,"healthyVolunteers":11,"sex":17,"minAge":4,"maxAge":4,"enrollmentInfo":58,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":60,"conditions":61,"keywords":63,"overallStatus":37,"whyStopped":4,"lastUpdateSubmitDate":66,"lastUpdatePostDateStruct":67,"startDateStruct":69,"completionDateStruct":71,"leadSponsor":73,"locationsCount":75},"100640758","deep-rectus-sheath-drs-block-in-abdominal-surgery-100640758","NCT07586462","Deep Rectus Sheath (DRS) Block in Abdominal Surgery","The Effectiveness of the Deep Rectus Sheath (Preperitoneal) Block for Postoperative Analgesia in Abdominal Surgery: A Prospective Observational Clinical Study","DRS block","Inclusion Criteria:\n\n* Age ≥ 18 years\n* Patients undergoing abdominal surgery, either open or laparoscopic\n* ASA physical status I-III\n* Neuraxial or general anesthesia according to standard clinical practice\n* Provision of informed consent to participate in the study\n\nExclusion Criteria:\n\n* Refusal to provide informed consent\n* Contraindications to locoregional anesthesia\n* Known allergy to local anesthetic agents\n* Coagulation disorders or incompatible anticoagulant therapy\n* Infection at the injection site\n* Cognitive impairment preventing reliable assessment of outcomes",{"count":59,"type":21},60,"The goal of this observational study is to learn about the effectiveness of the Deep Rectus Sheath (Preperitoneal) block in patients undergoing abdominal surgery. The main question it aims to answer is:\n\nDoes the Deep Rectus Sheath block improve postoperative recovery and pain control compared to standard care or other fascial plane blocks in patients undergoing abdominal surgery?\n\nParticipants undergoing open or laparoscopic abdominal surgery as part of their routine clinical care will receive analgesic management according to standard practice, which may include systemic analgesia alone, Deep Rectus Sheath block, or other fascial plane blocks (such as TAP, ESP, or QL), depending on anesthesiologist choice. Postoperative outcomes will be collected prospectively, including quality of recovery (QoR-15 at 24 hours), pain scores at rest and during movement up to 48 hours, analgesic consumption, time to first analgesic request, mobilization time, and occurrence of complications.",[29,62],"Abdominal Surgery by Laparotomy",[64,65,29],"rectus sheath","fascial blocks","2026-05-18",{"date":68,"type":41},"2026-05-22",{"date":70,"type":21},"2026-05",{"date":72,"type":21},"2027-05",{"name":74,"class":48},"San Giovanni di Dio Hospital",2,{"id":77,"slug":78,"hasResults":11,"nctId":79,"briefTitle":80,"officialTitle":81,"acronym":4,"eligibilityCriteria":82,"healthyVolunteers":11,"sex":83,"minAge":84,"maxAge":85,"enrollmentInfo":86,"targetDuration":88,"studyType":22,"phases":4,"briefSummary":89,"conditions":90,"keywords":94,"overallStatus":96,"whyStopped":4,"lastUpdateSubmitDate":97,"lastUpdatePostDateStruct":98,"startDateStruct":100,"completionDateStruct":102,"leadSponsor":104,"locationsCount":4},"100629972","laparoscopic-sclerotherapy-for-the-management-of-ovarian-endometriomas-100629972","NCT07481617","Laparoscopic Sclerotherapy for the Management of Ovarian Endometriomas","Laparoscopic Sclerotherapy for Management of Endometriomas: A Pilot Study Evaluating Impact on Ovarian Reserve","Inclusion Criteria:\n\n* English speaking\n* Age of 18 or greater\n* At least one ovarian endometrioma \\> 4 cm in size\n* Desires to proceed with surgical management of the endometrioma\n\nExclusion Criteria:\n\n* Known diminished ovarian reserve (AMH \\\u003C 1.0)\n* Known allergies to ethanol solutions\n* Pregnancy","FEMALE","18 Years","55 Years",{"count":87,"type":21},20,"6 Weeks","The objective of this study is to evaluate the effect of laparoscopic sclerotherapy on ovarian reserve and its overall efficacy in the treatment of endometriomas. Ovarian reserve will be assessed using preoperative and postoperative anti-Müllerian hormone (AMH) levels and antral follicle count (AFC). Traditionally, ovarian endometriomas are managed by complete cystectomy; however, multiple studies including a large systematic review and meta-analysis-have demonstrated that cystectomy significantly reduces ovarian reserve, with an average decline in AMH of 1.77 ng\u002FmL within one to six weeks postoperatively without recovery to baseline after many months. Sclerotherapy has historically been a potential alternative, typically performed by interventional radiology via transvaginal, transabdominal, or transgluteal drainage. This percutaneous approach, however, precludes direct visualization of the cyst and surgical management of concurrent conditions including endometriosis peritoneal disease, excision, adhesions, or tubal disease.\n\nSeveral studies have explored the feasibility and effectiveness of laparoscopic sclerotherapy, reporting encouraging results regarding its safety, increased AFC compared with cystectomy, and comparable pregnancy rates. Nonetheless, none of these studies have been conducted in the United States, and few have utilized a laparoscopic approach. Further research is therefore warranted to establish the accessibility and reproducibility of this technique. The investigators aim to conduct the first U.S.-based study evaluating the impact of laparoscopic sclerotherapy on ovarian reserve. The primary outcome will be the change in AMH and AFC at six weeks postoperatively. Consistent with prior evidence, the investigators hypothesize that laparoscopic sclerotherapy will result in a smaller decline in ovarian reserve compared with traditional cystectomy.",[91,92,93,29],"Endometriosis","Endometrioma","Sclerotherapy",[95],"laparoscopic sclerotherapy","NOT_YET_RECRUITING","2026-04-23",{"date":99,"type":41},"2026-04-29",{"date":101,"type":21},"2026-05-16",{"date":103,"type":21},"2027-08-30",{"name":105,"class":48},"Northwestern University",{"id":107,"slug":108,"hasResults":11,"nctId":109,"briefTitle":110,"officialTitle":111,"acronym":4,"eligibilityCriteria":112,"healthyVolunteers":16,"sex":83,"minAge":84,"maxAge":4,"enrollmentInfo":113,"targetDuration":4,"studyType":115,"phases":116,"briefSummary":118,"conditions":119,"keywords":4,"overallStatus":37,"whyStopped":4,"lastUpdateSubmitDate":125,"lastUpdatePostDateStruct":126,"startDateStruct":128,"completionDateStruct":130,"leadSponsor":132,"locationsCount":49},"100554837","low-versus-standard-pressure-pneumoperitoneum-on-shoulder-tip-pain-100554837","NCT06504277","Low Versus Standard Pressure Pneumoperitoneum on Shoulder Tip Pain","A Randomized Controlled Trial (RCT) Comparing the Effect of Low Versus Standard Pressure Pneumoperitoneum on Post-operative Shoulder Tip Pain in Patients Undergoing Laparoscopic Gynecologic Surgery for Benign Indications","Inclusion Criteria: The participant must meet all of the inclusion criteria to eligible for this clinical trial:\n\n1. All ages \\> or = to 18 years old;\n2. Must be deemed to have capacity to provide informed consent;\n3. Must sign and date the informed consent form;\n4. Stated willingness to comply with all study procedures;\n5. Must be undergoing unilateral or bilateral salpingo-oopherectomy or salpingectomy or ovarian cystectomy;\n\nExclusion Criteria: An individual who meets any of the following criteria will be excluded from participation in this clinical trial:\n\n1. Previous midline laparotomy;\n2. Gynecological cancer beyond stage 1 disease;\n3. Chronic pain;\n4. Known diagnosis of endometriosis or evidence of endometriosis intra-operatively;\n5. Fibromyalgia;\n6. BMI \\>50;\n7. Language barrier;\n8. Inability to communicate or provide informed consent;",{"count":114,"type":21},82,"INTERVENTIONAL",[117],"NA","This proposed study is a single-center, double blind, parallel group RCT comparing the use of low (10 mm Hg) versus standard pressure (15 mm Hg) pneumoperitoneum at the time of benign gynecologic laparoscopic surgery. Patients will be randomized to the control group (standard pressure) or the intervention group (low pressure) and surgeons will be blinded to the study pressure. Data on post-operative recovery and pain scores will be recorded for each patient.",[120,121,29,122,123,124],"Surgery","Laparoscopic","Penumoperitoneum","Post-operative Pain","Post-operative Recovery","2025-07-28",{"date":127,"type":41},"2025-07-31",{"date":129,"type":41},"2025-07-02",{"date":131,"type":21},"2026-09-15",{"name":133,"class":48},"Mount Sinai Hospital, Canada",{"id":135,"slug":136,"hasResults":11,"nctId":137,"briefTitle":138,"officialTitle":139,"acronym":140,"eligibilityCriteria":141,"healthyVolunteers":11,"sex":17,"minAge":142,"maxAge":4,"enrollmentInfo":143,"targetDuration":4,"studyType":115,"phases":145,"briefSummary":146,"conditions":147,"keywords":149,"overallStatus":96,"whyStopped":4,"lastUpdateSubmitDate":155,"lastUpdatePostDateStruct":156,"startDateStruct":158,"completionDateStruct":160,"leadSponsor":162,"locationsCount":4},"100591436","post-discharge-monitoring-initiative-on-outcomes-of-post-surgical-patients-100591436","NCT06980402","Post-discharge Monitoring Initiative on Outcomes of Post-surgical Patients","Pragmatic Pilot Study of SKH@Home Post-discharge Monitoring Initiative on Outcomes of Surgical Patients","SKH@home","Inclusion Criteria:\n\n1. Patient is keen for home management\n2. Hemodynamically stable\n3. Able and willing to self-care and monitor \u002F Good social support\n4. Lives in Singapore's Northeast region\n\n   EITHER\n5. Diagnosed with intra-abdominal abscess requiring ongoing IV antibiotics as recommended by Infectious Diseases Specialist where necessary OR Diagnosed with liver abscess requiring ongoing IV antibiotics as recommended by Infectious Diseases Specialist where necessary AND Has undergone initial treatment (e.g., drainage if required) and is clinically improving\n\n   OR\n6. Underwent an uneventful straightforward bariatric surgical procedure, and has been monitored overnight without any immediate postoperative issues OR Underwent uneventful straightforward laparoscopic\u002F endoscopic\u002F minimally invasive surgery, and has been monitored for at least 6 hours without any immediate postoperative issues AND has no significant intraprocedural concerns by the operating surgeon\n\nExclusion Criteria:\n\n1. Unable to self-care \u002F no caregiver\n2. Requires daily review by the surgical team\n3. Suspicion of surgical complications requiring surgical intervention\n4. Requires post-discharge monitoring care for \\> 2 weeks\n5. Unregulated psychiatric disorders\n6. Daily flushing of drains required","21 Years",{"count":144,"type":21},1000,[117],"The investigators are conducting a prospective study to evaluate the SKH@Home programme, a post-discharge monitoring initiative for surgical patients. The aim of this study is to conduct a pragmatic, non-randomized pilot study to compare the SKH@Home programme with standard post-surgical care on patient outcomes.",[29,148],"Discharge Planning",[150,151,152,153,154],"Bariatric surgery","Laparoscopic surgery","Abdominal abscesses","Liver abscesses","Discharge planning","2025-05-12",{"date":157,"type":41},"2025-05-20",{"date":159,"type":21},"2025-06-01",{"date":161,"type":21},"2029-01-31",{"name":163,"class":48},"Sengkang General Hospital",{"id":165,"slug":166,"hasResults":11,"nctId":167,"briefTitle":168,"officialTitle":169,"acronym":4,"eligibilityCriteria":170,"healthyVolunteers":11,"sex":17,"minAge":171,"maxAge":172,"enrollmentInfo":173,"targetDuration":4,"studyType":115,"phases":174,"briefSummary":175,"conditions":176,"keywords":4,"overallStatus":37,"whyStopped":4,"lastUpdateSubmitDate":181,"lastUpdatePostDateStruct":182,"startDateStruct":184,"completionDateStruct":186,"leadSponsor":188,"locationsCount":49},"100452251","virtual-reality-training-for-laparoscopic-cholecystectomy-100452251","NCT05169073","Virtual Reality Training for Laparoscopic Cholecystectomy","The Impact of 3D Virtual Reality MRCP Rendering on Surgical Performance During Laparoscopic Cholecystectomy: A Pilot Study","Inclusion Criteria:\n\n* Referred for elective cholecystectomy for symptomatic cholecystolithiasis\u002Fchronic cholecystitis\n* Early cholecystectomy after acute biliary pancreatitis\n* Concomitant minor procedures (adhesiolysis, umbilical hernia repair, liver biopsy)\n* Sufficient quality of MRCP\n\nExclusion Criteria:\n\n* American Society of Anaesthesiologists (ASA) classification ≥ 4\n* Previous major open upper abdominal surgery\n* Suspicion for concomitant biliary disease (e.g. Mirizzi-Syndrome)\n* Robotic cholecystectomy\n* Planned open procedures","22 Years","45 Years",{"count":87,"type":21},[117],"Cholecystectomy is one the most frequent laparoscopic procedures worldwide. It is a safe and effective operation but intraoperative bile duct injury remains a relevant complication with serious consequences for the patient. Most of the complications occur due to a lack of knowledge of the anatomy or misidentification of the cystic duct. Thus, the study of the anatomy is a cornerstone of a successful procedure and the preoperative magnetic resonance cholangiopancreatography (MRCP) is a way to preoperatively determine relevant structures to avoid intraoperative incidents.\n\nThis trial has been designed to assess the effect of preoperative virtual reality training based on MRCP on intraoperative performance and outcome.",[177,178,179,180,29],"Virtual Reality","Gallbladder","Bile Duct Injury","Medical Education","2025-04-10",{"date":183,"type":41},"2025-04-15",{"date":185,"type":41},"2021-11-01",{"date":187,"type":21},"2026-06-30",{"name":189,"class":48},"University Hospital, Basel, Switzerland",{"id":191,"slug":192,"hasResults":11,"nctId":193,"briefTitle":194,"officialTitle":195,"acronym":4,"eligibilityCriteria":196,"healthyVolunteers":11,"sex":17,"minAge":84,"maxAge":197,"enrollmentInfo":198,"targetDuration":4,"studyType":115,"phases":200,"briefSummary":201,"conditions":202,"keywords":4,"overallStatus":96,"whyStopped":4,"lastUpdateSubmitDate":206,"lastUpdatePostDateStruct":207,"startDateStruct":209,"completionDateStruct":211,"leadSponsor":213,"locationsCount":49},"100524167","ratme-vs-latme-in-middle-and-low-rectal-cancer-100524167","NCT06105203","RATME Vs LATME in Middle and Low Rectal Cancer","A Multicenter Randomized Clinical Trial to Assess the Advantages of Robotic Total Mesorectal Excision in Preserving External Sphincter in Patients with Middle and Low Rectal Cancer.","Inclusion Criteria:\n\n1. male patients diagnosed with rectal cancer by pathological biopsy;\n2. abdominal contrast-enhanced and chest computed tomography (CT) or positron emission tomography-computed tomography (PET-CT) revealed no distal metastasis;\n3. Preoperative rectal magnetic resistance (MR) evaluation showed that the tumor was located at or below the peritoneal reflux plane, and at least 1cm above the anal sphincter groove, and did not invade the external anal sphincter;\n4. Tumors located above the hiatus of levator ani muscle were evaluated by magnetic resonance imaging as cT1-3, cN0-1, M0, and MRF (-); The tumors located below the hiatus of levator ani muscle were evaluated by magnetic resonance imaging as cT1-2, cN0-1, M0, and MRF (-). After neoadjuvant treatment, the tumor above the hiatus of levator ani muscle is ycT3NxM0 or below; The tumor below the hiatus of levator ani muscle is ycT2NxM0;\n5. The patient underwent laparoscopic assisted TME surgery or robotic assisted TME surgery.\n\nExclusion Criteria:\n\n1. multiple primary cancers;\n2. history of open surgery;\n3. no preoperative MR evaluation and inadequate evaluation of tumor stage;\n4. Patients with rectal cancer who undergo endoscopic resection first and need subsequent transabdominal resection;\n5. Pregnant or patients with concomitant inflammatory bowel disease;\n6. Patients with preoperative complete bowel obstruction or requiring emergency surgery;\n7. Preoperative evaluation indicates that patient may require combined organ resection;\n8. Recently receiving treatment for other malignant tumors;\n9. Bordeaux type IV low rectal cancer;\n10. The preoperative pathological types are signet ring cell carcinoma, mucinous adenocarcinoma, undifferentiated carcinoma, or poorly differentiated carcinoma.\n\nExit Criteria\n\n1. Refuse surgical treatment after randomization;\n2. Open surgery was performed for treatment after randomization;\n3. Patients request to withdraw from the study at any time during the entire study process after randomization","75 Years",{"count":199,"type":21},1026,[117],"This is a multicenter, superior, randomized controlled trial designed to compare Robotic-assisted total mesorectal excision (RATME) and laparoscopic-assisted total mesorectal excision (LATME) for middle and low rectal cancer. The primary endpoint is the incidence of intersphincteric resection (ISR). The secondary outcomes are coloanal anastomosis (CAA), conversion to open, conversion to transanal TME (TaTME), incidence of abdominoperineal resection (APR), postoperative morbidity and mortality within 30 days after surgery, pathological outcomes, long-term survival outcomes, functional outcomes, and quality of life.",[203,204,205,29],"Total Mesorectal Excision","Rectal Neoplasms","Robotic Surgical Procedures","2025-02-16",{"date":208,"type":41},"2025-02-19",{"date":210,"type":21},"2025-11-01",{"date":212,"type":21},"2031-01",{"name":214,"class":48},"The First Hospital of Jilin University",{"id":216,"slug":217,"hasResults":11,"nctId":218,"briefTitle":219,"officialTitle":219,"acronym":220,"eligibilityCriteria":221,"healthyVolunteers":11,"sex":17,"minAge":84,"maxAge":4,"enrollmentInfo":222,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":224,"conditions":225,"keywords":227,"overallStatus":37,"whyStopped":4,"lastUpdateSubmitDate":235,"lastUpdatePostDateStruct":236,"startDateStruct":238,"completionDateStruct":240,"leadSponsor":242,"locationsCount":49},"100519543","multimodal-image-registration-for-helping-laparoscopic-liver-surgery-guidance-100519543","NCT06044909","Multimodal Image Registration for Helping Laparoscopic Liver Surgery Guidance","IMMORTALLS","Inclusion Criteria:\n\n* Patients undergoing hepatectomy;\n* Patients for whom good-quality imaging is available (CT scan and\u002For MRI and\u002For ultrasound);\n* Patients over 18 years of age;\n* Minimally invasive surgery by conventional or robot-assisted laparoscopy.\n\nExclusion Criteria:\n\n* Surgery by laparotomy",{"count":223,"type":21},40,"Multimodal intraoperative minimal-invasive (laparoscopic or robotic) liver surgery images will be registered to each other. Explicitly, these are the ultrasound and laparoscope images. Once they are registered, they will reveal the hidden tumor's location to the surgeon in real time through augmented reality. The intraoperative augmentation will also be enriched with the preoperative data (e.g., CT or MRI). This will simplify minimal invasive liver surgery, improve surgical safety and accuracy. It will also shorten hospital stays and contribute to an overall better quality of life for the patient, which in return will reduce the health-care costs.",[226,29],"Hepatectomy",[228,229,230,231,232,233,234],"Intraoperative","preoperative","multimodal data","registration","laparoscopy","hepatectomy","augmented reality","2024-09-19",{"date":237,"type":41},"2024-09-20",{"date":239,"type":41},"2023-09-15",{"date":241,"type":21},"2026-01",{"name":243,"class":48},"Centre Hospitalier Universitaire de Saint Etienne",{"id":245,"slug":246,"hasResults":11,"nctId":247,"briefTitle":248,"officialTitle":249,"acronym":4,"eligibilityCriteria":250,"healthyVolunteers":11,"sex":83,"minAge":84,"maxAge":251,"enrollmentInfo":252,"targetDuration":4,"studyType":115,"phases":254,"briefSummary":255,"conditions":256,"keywords":258,"overallStatus":37,"whyStopped":4,"lastUpdateSubmitDate":262,"lastUpdatePostDateStruct":263,"startDateStruct":265,"completionDateStruct":267,"leadSponsor":269,"locationsCount":49},"100552190","deep-neuromuscular-block-affect-the-quality-of-recovery-after-laparoscopic-hysterectomy-100552190","NCT06469866","Deep Neuromuscular Block Affect the Quality of Recovery After Laparoscopic Hysterectomy","Effect of Deep Neuromuscular Block on the Quality of Recovery After Laparoscopic Hysterectomy","Inclusion Criteria:\n\n* American Society of Anesthesiologists (ASA) physical status Ⅰ- Ⅲ\n* Scheduled for elective laparoscopic hysterectomy\n\nExclusion Criteria:\n\n* Inability to give informed consent\n* BMI \\>35\n* Renal or hepatic insufficiency\n* History of preoperative psychiatric\n* Previous surgery at procedure site\n* Neuromuscular disease, pregnancy, and contraindications to study medications.","65 Years",{"count":253,"type":21},72,[117],"BACKGROUND: Some studies have revealed that deep neuromuscular block (NMB) improve surgical conditions and alleviated postoperative pain compared with moderate NMB. The present study investigated deep NMB could improve the quality of recovery after laparoscopic hysterectomy\n\nMETHODS: seventy-two women with elective laparoscopic hysterectomy were randomly divided into 2 groups: Patients in group A received low-pressure pneumoperitoneum (LPP), which was set at 8-10 mmHg with deep NMB. Patients in group B received standard-pressure pneumoperitoneum (SPP), which was set at 12-14 mmHg with moderate NMB. Primary outcome was the quality of recovery (QoR-15) at 1 day after sugery. The secondary outcomes included postoperative pain, surgical condition, incidence of shoulder pain, the incidence of rescue analgesic drug use, cumulative dose of analgesics, time of first flatus, post-operative nausea and vomiting, time of tracheal tube removal.",[257,29],"Neuromuscular Blockade",[259,260,261],"Neuromuscular block","Recovery","Laparoscopic hysterectomy","2024-06-19",{"date":264,"type":41},"2024-06-24",{"date":266,"type":21},"2024-06-25",{"date":268,"type":21},"2024-11-25",{"name":270,"class":48},"Anqing Municipal Hospital"]